On June 30, 2025, RBC Capital analyst Ben Hendrix issued a new report concerning Chemed (CHE, Financial), maintaining the company's rating at "Outperform." Despite the consistent rating, the analyst has adjusted the price target for Chemed from the previous USD 674.00 to USD 640.00.
The adjustment reflects a 5.04% decrease in the price target. Investors following Chemed (CHE, Financial) should note this development as part of their portfolio assessments, given RBC Capital's continued "Outperform" rating. Chemed's performance and market conditions will be key factors to observe in the coming months.
While the price adjustment may signal caution, the "Outperform" rating suggests that Chemed (CHE, Financial) is still expected to perform better than the broader market averages. Investors are encouraged to stay informed about future analyses related to Chemed to make well-rounded investment decisions.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 3 analysts, the average target price for Chemed Corp (CHE, Financial) is $677.33 with a high estimate of $708.00 and a low estimate of $650.00. The average target implies an upside of 39.17% from the current price of $486.71. More detailed estimate data can be found on the Chemed Corp (CHE) Forecast page.
Based on the consensus recommendation from 3 brokerage firms, Chemed Corp's (CHE, Financial) average brokerage recommendation is currently 1.3, indicating "Buy" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for Chemed Corp (CHE, Financial) in one year is $675.54, suggesting a upside of 38.8% from the current price of $486.7096. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Chemed Corp (CHE) Summary page.